BSGM250117C5000
- 0.65
- 0.000.00%
BIOSIG TECHNOLOGIES INC Newsroom
Express News | Ascendiant Capital Maintains Buy on BioSig Technologies, Raises Price Target to $2.75
BioSig Technologies Analyst Ratings
BIOSIG TECHNOLOGIES INC | 10-Q: Q3 2024 Earnings Report
BioSig Regains Compliance With Nasdaq's Minimum Bid Price Requirement
Express News | BioSig Regains Compliance With Nasdaq’s Minimum Bid Price Requirement
12 Health Care Stocks Moving In Monday's After-Market Session
BioSig Technologies' Common Stock To Resume Trading On The Nasdaq Exchange, Wednesday, October 23, 2024 After Its Appeal Was Granted An Extension Until March 7, 2025
Express News | BioSig Technologies' Common Stock to Resume Trading on Nasdaq Exchange, October 23, 2024 After Its Successful Appeal to Nasdaq Panel
BioSig Technologies Announces Executive Leadership Overhaul
BIOSIG TECHNOLOGIES INC | 10-Q: Q2 2024 Earnings Report
Biosig Technologies: Proposed Acquisition Will Require Extensive Due Diligence, Potentially Through Yr-end >BSGM
Biosig Technologies Purchase Price Will Be Paid Through the Issue of Shrs to NKC Hldrs >BSGM
Express News | BioSig Technologies Announces Intent to Acquire the Assets of Neuro-Kinesis Corporation
BioSig Technologies Improves Balance Sheet, Announces Reduction in Outstanding Payables During Q2 2024
Sector Update: Health Care Stocks Softer Late Afternoon
Express News | BioSig Technologiesshares Are Trading Lower After the Company Was Notified by the Nasdaq Hearings Panel That Its Common Stock Will Be Delisted From the Nasdaq Stock Market Due to Non-compliance With the Minimum Stockholders' Equity Requirement
Why BioSig Technologies (BSGM) Shares Are Down Over 60%
Express News | BioSig Technologies Shares Halted On Circuit Breaker To The Downside, Stock Now Down -40.2%
Express News | BioSig Technologies Inc - on June 10, Co Got Formal Notice That Nasdaq Hearings Panel Had Determined to Delist Company's Common Stock
12 Health Care Stocks Moving In Tuesday's Intraday Session